Please login to the form below

Not currently logged in
Email:
Password:

Recipharm Italy appoints new general manager

Dr Giorgio Bruno has worked with companies such as AstraZeneca and Corden

Recipharm Giorgio BrunoCMO firm Recipharm has appointed Dr Giorgio Bruno as its new general manager of Recipharm Italia.

In this role, he will serve as CEO for all of Recipharm's Italian operating companies which employ some 257 people at three sites and have revenues of €57m.

Dr Bruno has long established senior management experience from within the pharmaceutical industry, especially in the area of manufacturing. 

He has worked in both Italian and multinational pharma companies covering a wide range of disciplines. 

In particular he has had responsibility for quality and manufacturing at such companies including Parke Davis, AstraZeneca and Corden Pharma. 

He holds a PhD in Pharmaceutical Chemistry and Technology from the University of Milan. 

Thomas Eldered, CEO of Recipharm, said: “I am very pleased to welcome Dr Bruno to the Recipharm team. We are very fortunate to have been able to attract such a competent and highly experienced manager to this important position and I look forward to him bringing his expertise to bear across our Italian operations for which he is now responsible.” 

24th April 2015

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics